Zobrazeno 1 - 10
of 43
pro vyhledávání: ''
Publikováno v:
The American Journal of Medicine. 118:7-13
In the outpatient setting, genitourinary infections (GUIs) remain costly to treat and are a significant cause of morbidity. Recent evidence supports more substantial roles for pathogens other than Escherichia coli, particularly gram-positive pathogen
Publikováno v:
The American Journal of Medicine. 107:55-61
Individual comparative studies suggest that nabumetone has a gastrointestinal (GI) safety profile superior to comparator NSAIDs but lack power to show a statistical difference. The aim of this study was to evaluate systematically the difference in GI
Publikováno v:
The American Journal of Medicine
This review provides a practical, simple, and logical approach to the diagnosis and management of patients with acute infectious diarrhea, one of the most common diagnoses in clinical practice. Diarrhea in the immunocompromised host, traveler's diarr
Publikováno v:
The American Journal of Medicine. 118:1347-1349
Publikováno v:
The American Journal of Medicine. 100:76S-82S
Clinical and in vitro data indicate that cefepime, a fourth-generation cephalosporin, may be a valuable addition in the treatment of serious infections. In this study, hospitalized patients with complicated and uncomplicated urinary tract infection (
Publikováno v:
The American Journal of Medicine. 129:e33
Enakpene et al inform electrocardiogram alterations related to loperamide abuse. Because the drug is available over the counter, unregulated use is frequent to control gastrointestinal symptoms, mainly diarrhea and unfortunately as an increasing noni
Publikováno v:
The American journal of medicine. 125(4)
Objective Current treatment options for irritable bowel syndrome are limited and often poorly studied. A select few drugs have been studied in irritable bowel syndrome, and the number needed to treat is frequently used to assess the relative efficacy
Autor:
Pedro Leal Del Rosal, Giuseppe Pastore, H. Iskandar, Auguste Kadio, Somsak Lolekha, Ethan Rubinstein, C. Rasidi, Thomas Butler
Publikováno v:
The American Journal of Medicine. 94:187S-194S
This study was designed to test the efficacy of 400 mg fleroxacin given orally as a single dose or once daily for 3 days against acute bacterial diarrhea. A group of 508 adults with acute diarrhea were entered into a randomized, double-blind, placebo
Autor:
Michael L. Zeckel
Publikováno v:
The American Journal of Medicine. 92:S58-S64
Two controlled clinical trials compared loracarbef (LY163892 with amoxicillin/clavulanate or amoxicillin in the treatment of acute exacerbations of chronic bronchitis. Collectively, of 1,057 patients enrolled, 390 qualified for analysis: group 1 comp
Publikováno v:
The American Journal of Medicine. 91:S151-S157
Sucralfate, an aluminum hydroxide complex of sulfated sucrose used in the treatment of gastric ulcer, was shown to prevent irradiation-induced diarrhea and bowel discomfort significantly in patients treated for pelvic cancer with external radiotherap